We studied by quantitative real-time RT–PCR the expression of the seven semaphorins from class-3 (A-G), SEMA4D, NRP1, NRP2 and VEGF in 11 adult low-grade and 27 high-grade gliomas. This evidence concerns the gene SEMA4D and central nervous system cancer.